In particular, AKR1B10, revealed to be a differentially overexpressed gene in keloids through the whole-genome microarray analysis of lesions and normal tissue, and GDF-9, discovered through analysis using a TGF-β superfamily signaling gene chip, are attractive therapeutic targets [67,80]. This evidence concerns the gene GDF9 and keloid.